These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34473191)

  • 1. Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021.
    Uyoga S; Adetifa IMO; Otiende M; Yegon C; Agweyu A; Warimwe GM; Scott JAG
    JAMA; 2021 Oct; 326(14):1436-1438. PubMed ID: 34473191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.
    Dodd RY; Spencer BR; Xu M; Foster GA; Saá P; Brodsky JP; Stramer SL
    Transfus Med Rev; 2021 Jul; 35(3):1-7. PubMed ID: 34373145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors.
    Vassallo RR; Dumont LJ; Bravo MD; Hazegh K; Kamel H
    Transfus Med Rev; 2021 Jul; 35(3):8-15. PubMed ID: 34376289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
    Uyoga S; Adetifa IMO; Karanja HK; Nyagwange J; Tuju J; Wanjiku P; Aman R; Mwangangi M; Amoth P; Kasera K; Ng'ang'a W; Rombo C; Yegon C; Kithi K; Odhiambo E; Rotich T; Orgut I; Kihara S; Otiende M; Bottomley C; Mupe ZN; Kagucia EW; Gallagher KE; Etyang A; Voller S; Gitonga JN; Mugo D; Agoti CN; Otieno E; Ndwiga L; Lambe T; Wright D; Barasa E; Tsofa B; Bejon P; Ochola-Oyier LI; Agweyu A; Scott JAG; Warimwe GM
    Science; 2021 Jan; 371(6524):79-82. PubMed ID: 33177105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand.
    Carlton LH; Chen T; Whitcombe AL; McGregor R; Scheurich G; Sheen CR; Dickson JM; Bullen C; Chiang A; Exeter DJ; Paynter J; Baker MG; Charlewood R; Moreland NJ
    Epidemiol Infect; 2021 Jul; 149():e173. PubMed ID: 34668464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020.
    Dodd RY; Xu M; Stramer SL
    JAMA; 2020 Oct; 324(16):1677-1679. PubMed ID: 32926078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria.
    Egger M; Bundschuh C; Wiesinger K; Bräutigam E; Berger T; Clodi M; Dieplinger B
    Clin Chem Lab Med; 2021 May; 59(6):e231-e234. PubMed ID: 33554543
    [No Abstract]   [Full Text] [Related]  

  • 10. Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.
    Adetifa IMO; Uyoga S; Gitonga JN; Mugo D; Otiende M; Nyagwange J; Karanja HK; Tuju J; Wanjiku P; Aman R; Mwangangi M; Amoth P; Kasera K; Ng'ang'a W; Rombo C; Yegon C; Kithi K; Odhiambo E; Rotich T; Orgut I; Kihara S; Bottomley C; Kagucia EW; Gallagher KE; Etyang A; Voller S; Lambe T; Wright D; Barasa E; Tsofa B; Bejon P; Ochola-Oyier LI; Agweyu A; Scott JAG; Warimwe GM
    Nat Commun; 2021 Jun; 12(1):3966. PubMed ID: 34172732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Yoshiyama T; Saito Y; Masuda K; Nakanishi Y; Kido Y; Uchimura K; Mitarai S; Suzuki T; Nakagama Y; Kubota H; Satomi M; Uchikoba S; Ohnishi M; Wakita T; Kato S; Kato K
    Emerg Infect Dis; 2021 Feb; 27(2):628-631. PubMed ID: 33496235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years - Mississippi, May-September 2020.
    Hobbs CV; Drobeniuc J; Kittle T; Williams J; Byers P; Satheshkumar PS; Inagaki K; Stephenson M; Kim SS; Patel MM; Flannery B;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):312-315. PubMed ID: 33661862
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units.
    Haizler-Cohen L; Davidov A; Blitz MJ; Fruhman G
    Am J Obstet Gynecol; 2021 Jan; 224(1):112-114. PubMed ID: 32971014
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Healthcare Workers.
    Wang RC; Murphy CE; Kornblith AE; Kurtz T; Kohn MA
    Ann Emerg Med; 2021 May; 77(5):556-557. PubMed ID: 33902837
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Kar SS; Sarkar S; Murali S; Dhodapkar R; Joseph NM; Aggarwal R
    Emerg Infect Dis; 2021 Feb; 27(2):666-669. PubMed ID: 33496645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors.
    Razafimahatratra SL; Ndiaye MDB; Rasoloharimanana LT; Dussart P; Sahondranirina PH; Randriamanantany ZA; Schoenhals M
    Lancet Glob Health; 2021 Oct; 9(10):e1363-e1364. PubMed ID: 34534478
    [No Abstract]   [Full Text] [Related]  

  • 18. Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients.
    Del Zompo F; De Maio F; Santopaolo F; Ricci R; Gasbarrini A; Pompili M; Ponziani FR
    Dig Liver Dis; 2021 May; 53(5):541-544. PubMed ID: 33707148
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.
    Nakamura A; Ando S; Endo H; Sato R
    J Med Virol; 2021 Jul; 93(7):4608-4611. PubMed ID: 33760273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.